Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials.
about
Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculatureTargeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference.Emerging drugs for the treatment of cervical cancer.Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.Addition of bevacizumab to systemic therapy for locally advanced and metastatic nasopharyngeal carcinoma.
P2860
Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Combining Bevacizumab with Rad ...... ationale, and Clinical Trials.
@ast
Combining Bevacizumab with Rad ...... ationale, and Clinical Trials.
@en
type
label
Combining Bevacizumab with Rad ...... ationale, and Clinical Trials.
@ast
Combining Bevacizumab with Rad ...... ationale, and Clinical Trials.
@en
prefLabel
Combining Bevacizumab with Rad ...... ationale, and Clinical Trials.
@ast
Combining Bevacizumab with Rad ...... ationale, and Clinical Trials.
@en
P2093
P2860
P1433
P1476
Combining Bevacizumab with Rad ...... ationale, and Clinical Trials.
@en
P2093
Benjamin Schmidt
Hae-June Lee
Sam S Yoon
Sandra Ryeom
P2860
P304
P356
10.2174/2211552811201030169
P577
2012-09-01T00:00:00Z